Cargando…
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...
Autores principales: | Narasimhan, Madhusudhanan, Mahimainathan, Lenin, Clark, Andrew E, Usmani, Amena, Cao, Jing, Araj, Ellen, Torres, Fernando, Sarode, Ravi, Kaza, Vaidehi, Lacelle, Chantale, Muthukumar, Alagarraju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310345/ https://www.ncbi.nlm.nih.gov/pubmed/34208884 http://dx.doi.org/10.3390/vaccines9070708 |
Ejemplares similares
-
Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
‘nAb’ the self-reactive activity in the COVID-19 combat
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group
por: Kim, Kangsan, et al.
Publicado: (2022) -
Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2023)